+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Peripheral Vascular Debulking Device Market - Global Forecast 2025-2030- Product Image
Peripheral Vascular Debulking Device Market - Global Forecast 2025-2030- Product Image
Sale

Peripheral Vascular Debulking Device Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6120798
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
Peripheral vascular disease continues to exert a profound clinical burden worldwide, compelling healthcare providers to adopt more effective treatment modalities. Debulking devices, engineered to precisely remove atherosclerotic plaque from peripheral arteries, represent a pivotal innovation in this landscape. The advent of directional, laser, orbital, and rotational atherectomy platforms has introduced new therapeutic avenues, enabling interventionalists to tailor procedures with enhanced procedural accuracy and safety. As the prevalence of peripheral artery disease rises, the imperative to refine minimally invasive techniques becomes more urgent, driving sustained investment in device development.

Against this backdrop, stakeholders across the value chain-including manufacturers, clinicians, and payers-are aligning on the promise of improved patient outcomes and reduced long-term healthcare costs. The integration of imaging enhancements and adjunctive technologies alongside debulking systems demonstrates an ongoing commitment to optimizing lesion preparation and vessel patency. In parallel, reimbursement frameworks are evolving to recognize the procedural efficiencies and clinical benefits of advanced debulking therapies. Consequently, market participants must navigate a dynamic interplay of clinical demand, technological progress, and regulatory oversight to fully capitalize on the transformative potential of these devices.

Navigating Disruptive Technological Breakthroughs and Regulatory Reforms Shaping Next Generation Peripheral Vascular Debulking Solutions

Recent years have witnessed a confluence of technological breakthroughs and regulatory reforms reshaping the peripheral vascular debulking device space. Innovations in micro-oscillating orbital systems, high-precision excimer lasers, and next-generation atherectomy catheters are expanding the procedural toolkit available to interventional teams. These advances are complemented by real-time imaging integration and intelligent robotics, which enhance operator control and lesion visualization. Consequently, procedural safety profiles have improved, enabling more complex lesion subsets to be addressed with confidence.

Meanwhile, regulatory bodies have introduced streamlined pathways for devices demonstrating substantial equivalence to predicate systems, accelerating time to market for incremental upgrades. Quality standards have also evolved, driving manufacturers to adopt robust post-market surveillance and risk-management protocols. Additionally, reimbursement landscapes in key markets are shifting to reward demonstrable clinical value rather than device volume alone. Together, these shifts are catalyzing a more innovation-driven ecosystem, where agility in development and responsiveness to stakeholder feedback determine commercial success.

Assessing the Comprehensive Impact of the 2025 United States Tariff Policy on Peripheral Vascular Debulking Device Supply Chains and Pricing Dynamics

The imposition of new tariffs by the United States in 2025 has introduced a fresh layer of complexity to the peripheral vascular device arena. Many debulking systems and their critical components rely on specialized alloys, precision-engineered catheters, and high-cost laser modules sourced through global supply chains. As duties increase on imported medical device components, manufacturers are reconfiguring procurement strategies to mitigate cost pressures. Some providers are accelerating onshore production, while others are renegotiating supplier agreements to preserve margin stability.

In response, contract manufacturers and device developers are also exploring partnerships with regional distribution centers to localize inventory buffers. This adjustment has, in turn, reshaped logistics models and influenced product launch timelines. On the purchasing side, hospitals and ambulatory centers are scrutinizing total cost of ownership, factoring in tariff-induced price escalations. Consequently, commercial teams are emphasizing demonstrable value propositions, including shorter procedure times, lower complication rates, and reduced hospitalization durations. Overall, the 2025 tariff measures have underscored the importance of supply chain agility and adaptive pricing strategies in maintaining market momentum.

Uncovering In-Depth Market Segmentation Insights Across Device Type Indications Access Modalities and Distribution Structures Fueling Tailored Strategic Planning

A deep dive into market segmentation illuminates nuanced avenues for targeted growth and differentiated strategies. The product spectrum encompasses directional atherectomy devices available in SilverHawk and TurboHawk platforms, laser systems featuring both Excimer and Nd:YAG modalities, orbital atherectomy solutions ranging from conventional orbital to micro-oscillating variants, and rotational atherectomy technologies exemplified by Jetstream and Peripheral Rotablator designs. Each category offers distinct clinical benefits and engineering complexities that appeal to varied procedural preferences.

End users span ambulatory surgery centers, outpatient clinics, and hospitals, with specialized adoption in dedicated cardiology and vascular surgery departments. Within these settings, patient profiles vary widely, from those suffering carotid artery stenosis to individuals with chronic critical limb ischemia or renal artery stenosis. Peripheral artery disease remains a core indication, driving demand across all device types. Distribution strategies further bifurcate between direct sales models, which facilitate close collaboration with key opinion leaders, and distributor networks that broaden geographic reach. Meanwhile, access site considerations-whether brachial, femoral, or radial-shape device design and clinical training priorities. This segmentation framework empowers stakeholders to align product portfolios with specific clinical workflows and institutional procurement approaches.

Examining Regional Growth Drivers and Market Penetration Trends in the Americas, Europe, Middle East & Africa, and Asia Pacific Peripheral Vascular Sectors

Regional dynamics exert a profound influence on deployment trajectories and competitive landscapes. In the Americas, robust reimbursement pathways and high adoption rates of minimally invasive therapies have positioned the United States as a global innovation leader. Latin American markets, while smaller in scale, are increasingly receptive to cost-effective debulking solutions, particularly in urban centers with well-established cardiovascular care networks.

Across Europe, the Middle East, and Africa, heterogeneous regulatory regimes and reimbursement frameworks create both opportunities and challenges. Western European nations often demonstrate accelerated uptake of premium systems, whereas certain EMEA markets prioritize budget-friendly technologies and contract tende­r agreements. Importantly, a growing emphasis on value-based care is encouraging providers to adopt evidence-backed debulking platforms that deliver predictable long-term outcomes.

In the Asia-Pacific region, expanding healthcare infrastructure and rising cardiovascular disease prevalence are catalyzing market growth. Japan and Australia lead in early technology adoption and comprehensive training programs, while emerging markets in Southeast Asia and India seek to balance cost constraints with clinical effectiveness. Collaborative initiatives between device makers and local p­artners are instrumental in navigating regulatory approvals and reimbursement negotiations in the Asia-Pacific arena.

Profiling Leading Manufacturers Competitive Strategies and Innovation Pathways Dominating the Peripheral Vascular Debulking Device Landscape

Several industry leaders are distinguishing themselves through sustained investment in research and development, strategic acquisitions, and collaborative clinical studies. Key atherectomy device innovators have prioritized next-generation product pipelines, focusing on miniaturization, integrated imaging capabilities, and smart navigation algorithms designed to optimize plaque removal. These efforts are complemented by partnerships with academic centers and industry consortia, which facilitate robust real-world evidence generation and accelerate regulatory submissions.

Moreover, certain players have leveraged M&A activity to broaden their portfolio across complementary technologies, enhancing cross-selling opportunities within existing customer bases. Others are adopting direct-to-physician engagement models, supported by dedicated training academies and digital education platforms, to foster familiarity with novel device features. Additionally, collaborative efforts with reimbursement experts are helping secure favorable coverage determinations, further reinforcing competitive positioning. Ultimately, success in this market hinges on the ability to fuse technological differentiation with pragmatic commercialization strategies.

Implementing Actionable Tactics and Strategic Recommendations to Propel Market Leadership in the Evolving Peripheral Vascular Debulking Device Domain

To capitalize on evolving market dynamics, industry leaders should prioritize the integration of multifunctional device platforms that combine atherectomy with adjunctive therapies such as drug-coated balloons and intravascular imaging. Embracing modular designs can streamline procedural workflows and reduce training burdens. Concurrently, expanding supply chain diversification-such as establishing regional manufacturing hubs-will buffer against tariff fluctuations and logistical disruptions.

Organizations should also deepen collaborations with key opinion leaders and health economics specialists to articulate clear value propositions. By generating robust cost-utility analyses and long-term outcome data, companies can strengthen reimbursement dossiers and support premium pricing. Furthermore, investing in digital health solutions that enable remote procedure monitoring and predictive maintenance of device systems will enhance customer engagement and foster ongoing product loyalty. Finally, continuous professional education initiatives should be deployed to ensure widespread clinical mastery and accelerate adoption across diverse healthcare settings.

Detailing the Rigorous Multimodal Research Methodology Incorporating Primary Interviews Secondary Analysis and Clinical Evidence Synthesis

This research initiative employed a comprehensive methodology combining structured primary interviews with leading interventional cardiologists, vascular surgeons, and procurement executives. Insights gleaned from these dialogues were triangulated with secondary data sources, including peer-reviewed clinical studies, regulatory filings, and published health economics analyses. Device manufacturers provided technical specifications, product roadmaps, and post-market performance metrics under strict confidentiality agreements.

Quantitative data were synthesized using advanced analytics to identify meaningful correlations between device attributes and procedural outcomes. Additionally, a panel of clinical and market access experts vetted preliminary findings to ensure rigor and relevance. Geographic market trends were corroborated through collaboration with regional specialists familiar with local regulatory and reimbursement environments. Finally, iterative validation workshops refined strategic recommendations, guaranteeing that the final report presents actionable intelligence anchored in real-world evidence and current practice patterns.

Synthesizing Core Findings and Strategic Implications to Guide Stakeholders in Optimizing Peripheral Vascular Debulking Device Investments and Innovations

The convergence of advanced atherectomy technologies, evolving reimbursement paradigms, and global supply chain realignments underscores a pivotal moment for peripheral vascular debulking device stakeholders. The groundwork laid by directional, laser, orbital, and rotational platforms has established a robust foundation for next-generation innovations that promise improved safety, efficiency, and long-term vessel patency. Meanwhile, the 2025 tariff landscape has highlighted the imperative for agile manufacturing strategies and compelling value narratives.

Segmented insights across product types, end users, clinical indications, distribution channels, and access sites reveal multifaceted growth levers and potential bottlenecks. Regional analyses further illuminate the nuanced pathways to market, from the United States’ advanced reimbursement infrastructure to the Asia-Pacific’s rapid infrastructure build-out. Leading manufacturers that align technology roadmaps with clinician needs, economic imperatives, and regulatory realities will be best positioned to capture emerging opportunities.

By synthesizing these findings, stakeholders can formulate robust market entry strategies, optimize R&D investments, and foster sustainable competitive advantages. Ultimately, the ability to translate data-driven insights into decisive action will determine the next generation of market leaders in peripheral vascular debulking.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • Directional Atherectomy
      • SilverHawk
      • TurboHawk
    • Laser Atherectomy
      • Excimer Laser
      • NdYag Laser
    • Orbital Atherectomy
      • Conventional Orbital
      • Micro-Oscillating
    • Rotational Atherectomy
      • Jetstream
      • Peripheral Rotablator
  • End User
    • Ambulatory Surgery Center
    • Clinic
    • Hospital
      • Cardiology Department
      • Vascular Surgery Department
  • Clinical Indication
    • Carotid Artery Stenosis
    • Critical Limb Ischemia
    • Peripheral Artery Disease
    • Renal Artery Stenosis
  • Distribution Channel
    • Direct Sales
    • Distributor Sales
  • Access Site
    • Brachial Access
    • Femoral Access
    • Radial Access
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Cardiovascular Systems, Inc.
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Medtronic plc
  • Straub Medical Group AG
  • Avinger, Inc.
  • Terumo Corporation
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cook Medical LLC

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Increasing adoption of orbital atherectomy systems with enhanced dual ring technology for complex calcified lesions
5.2. Integration of intravascular imaging modalities like IVUS and OCT to optimize debulking device placement and outcomes
5.3. Expansion of combination therapy protocols pairing debulking devices with drug coated balloons to reduce restenosis rates
5.4. Regulatory and reimbursement reforms favoring minimally invasive peripheral vascular procedures and innovative debulking technologies
5.5. Emergence of artificial intelligence guided catheter navigation systems to enhance precision during peripheral debulking interventions
5.6. Development of robotic assisted peripheral vascular debulking platforms to improve operator control and patient safety
5.7. Rising focus on distal embolic protection filter integration to mitigate complications in complex lesion debulking procedures
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Peripheral Vascular Debulking Device Market, by Product Type
8.1. Introduction
8.2. Directional Atherectomy
8.2.1. SilverHawk
8.2.2. TurboHawk
8.3. Laser Atherectomy
8.3.1. Excimer Laser
8.3.2. NdYag Laser
8.4. Orbital Atherectomy
8.4.1. Conventional Orbital
8.4.2. Micro-Oscillating
8.5. Rotational Atherectomy
8.5.1. Jetstream
8.5.2. Peripheral Rotablator
9. Peripheral Vascular Debulking Device Market, by End User
9.1. Introduction
9.2. Ambulatory Surgery Center
9.3. Clinic
9.4. Hospital
9.4.1. Cardiology Department
9.4.2. Vascular Surgery Department
10. Peripheral Vascular Debulking Device Market, by Clinical Indication
10.1. Introduction
10.2. Carotid Artery Stenosis
10.3. Critical Limb Ischemia
10.4. Peripheral Artery Disease
10.5. Renal Artery Stenosis
11. Peripheral Vascular Debulking Device Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Distributor Sales
12. Peripheral Vascular Debulking Device Market, by Access Site
12.1. Introduction
12.2. Brachial Access
12.3. Femoral Access
12.4. Radial Access
13. Americas Peripheral Vascular Debulking Device Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Peripheral Vascular Debulking Device Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Peripheral Vascular Debulking Device Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Cardiovascular Systems, Inc.
16.3.2. Koninklijke Philips N.V.
16.3.3. Boston Scientific Corporation
16.3.4. Medtronic plc
16.3.5. Straub Medical Group AG
16.3.6. Avinger, Inc.
16.3.7. Terumo Corporation
16.3.8. Abbott Laboratories
16.3.9. B. Braun Melsungen AG
16.3.10. Cook Medical LLC
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET: RESEARCHAI
FIGURE 26. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET: RESEARCHSTATISTICS
FIGURE 27. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET: RESEARCHCONTACTS
FIGURE 28. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY SILVERHAWK, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY TURBOHAWK, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY EXCIMER LASER, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY NDYAG LASER, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CONVENTIONAL ORBITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY MICRO-OSCILLATING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY JETSTREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ROTABLATOR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CARDIOLOGY DEPARTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY VASCULAR SURGERY DEPARTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CAROTID ARTERY STENOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CRITICAL LIMB ISCHEMIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PERIPHERAL ARTERY DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RENAL ARTERY STENOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY BRACHIAL ACCESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY FEMORAL ACCESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY RADIAL ACCESS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 123. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 124. UNITED STATES PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 125. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 126. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 127. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 128. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 129. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 130. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 131. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 132. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 133. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 134. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 135. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 138. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 139. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 140. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 141. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 144. CANADA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 145. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 146. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 147. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 148. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 149. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 150. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 151. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 152. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 153. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 154. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 155. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 158. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 159. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 160. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 161. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 164. MEXICO PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 184. BRAZIL PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 203. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 204. ARGENTINA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 225. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 226. EUROPE, MIDDLE EAST & AFRICA PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 246. UNITED KINGDOM PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 247. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 248. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 249. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 250. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 251. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 252. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 253. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 254. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 255. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 256. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 257. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 260. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2025-2030 (USD MILLION)
TABLE 261. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2018-2024 (USD MILLION)
TABLE 262. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY CLINICAL INDICATION, 2025-2030 (USD MILLION)
TABLE 263. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2018-2024 (USD MILLION)
TABLE 266. GERMANY PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ACCESS SITE, 2025-2030 (USD MILLION)
TABLE 267. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 268. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 269. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 270. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY DIRECTIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 271. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 272. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY LASER ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 273. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 274. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ORBITAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 275. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2018-2024 (USD MILLION)
TABLE 276. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY ROTATIONAL ATHERECTOMY, 2025-2030 (USD MILLION)
TABLE 277. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. FRANCE PERIPHERAL VASCULAR DEBULKING DEVICE MARKET SIZE, BY HOSPITAL, 2018-2024 (USD MILLION)
TABLE 280. FRANCE PERIPHERAL VASCULAR DEBULKING DE

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Peripheral Vascular Debulking Device market report include:
  • Cardiovascular Systems, Inc.
  • Koninklijke Philips N.V.
  • Boston Scientific Corporation
  • Medtronic plc
  • Straub Medical Group AG
  • Avinger, Inc.
  • Terumo Corporation
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Cook Medical LLC

Related Topics

Related Reports

Atherectomy Devices Market - Global Forecast 2025-2030 - Product Image

Atherectomy Devices Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Peripheral Vascular Interventional Devices Market - Global Forecast 2025-2030 - Product Image

Peripheral Vascular Interventional Devices Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Atherectomy Devices Market Report by Product Application, End User, and Region 2025-2033 - Product Image

Atherectomy Devices Market Report by Product Application, End User, and Region 2025-2033

  • Report
  • 137 Pages
  • Global
From
Coronary Atherectomy Devices Market Report 2025 - Product Image

Coronary Atherectomy Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Peripheral Vascular Devices and Equipment Market Report 2025 - Product Image

Peripheral Vascular Devices and Equipment Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.